top of page
  • Blood Borne Viruses
    Hepatitis A Virus (HAV) Hepatitis E Virus (HEV) Parvovirus B19
  • Enteric Viruses and Bacteria
    Clostridium difficile EHEC Norovirus Rotavirus
  • Human Adenovirus, Human Herpesvirus and Polyomavirus
    Human adenovirus (ADV) Cytomegalovirus (CMV) Epstein-Barr Virus (EBV) Human Herpesvirus 6A and 6B (HHV-6) Herpes Simplex Virus 1 and 2 (HSV) Varicella-Zoster Virus (VZV) BK Virus (BKV) JC Virus (JCV)
  • Respiratory Viruses, Bacteria and Fungi
    Human adenovirus (ADV) Enterovirus (ENV) and Rhinovirus (RHV) Human Influenza A and B and SwineFlu Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Human Metapneumovirus A and B (hMPV) Human Parainfluenza Virus 1– 4 (PIV) Respiratory Syncytial Virus A and B (RSVA and RSVB) Bordetella pertussis and Bordetella parapertussis Pneumocystis jirovecii
  • Tropical and other Viruses, Bacteria and Parasites
    AHFV/KFDV CCHFV Chagas Chikungunya Dengue Ebolavirus Filovirus Lassa Virus Malaria Rift Valley Fever Trichomonas vaginalis WNV Yellow Fever Zika Virus
RCPABanner.png

The Royal College of Pathologists of Australasia, or RCPA, has long supported excellence in provision of external quality assurance (EQA) for pathology laboratories. Quality assurance programs began in 1968 in Chemical Pathology, Hematology, Blood Bank, Microbiology and Anatomical Pathology. These discipline-specific programs were originally offered by independent organisation that became increasingly large and complex. 



Our Program Options:

RCPA-QAP_RGB_logo_300dpi.png
bottom of page